英诺特业绩快报:2025年归母净利润1.46亿元,同比下降40.84%

Core Viewpoint - The company reported a significant decline in both revenue and net profit for the fiscal year 2025, indicating potential challenges in its operational performance [1] Financial Performance - The company achieved a revenue of 422 million yuan, representing a year-on-year decrease of 32.08% [1] - The net profit attributable to shareholders was 146 million yuan, reflecting a year-on-year decline of 40.84% [1] - The basic earnings per share stood at 1.07 yuan [1]

Innovita Biological Technology -英诺特业绩快报:2025年归母净利润1.46亿元,同比下降40.84% - Reportify